Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Effect of Antiplatelet Drugs on D-Dimer Levels: A Systematic Review and Meta-analysis.

Morelli F, Schol-Gelok S, Arends LR, Boersma E, Kruip MJHA, Versmissen J, van Gelder T.

J Cardiovasc Pharmacol. 2019 Jun;73(6):343-351. doi: 10.1097/FJC.0000000000000670.

PMID:
31162242
2.

A revised systematic review and meta-analysis on the effect of statins on D-dimer levels.

Schol-Gelok S, Morelli F, Arends LR, Boersma E, Kruip MJHA, Versmissen J, van Gelder T.

Eur J Clin Invest. 2019 Aug;49(8):e13130. doi: 10.1111/eci.13130. Epub 2019 Jun 3. Review.

PMID:
31112290
3.

The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines.

Dreijer AR, Diepstraten J, Leebeek FWG, Kruip MJHA, van den Bemt PMLA.

Int J Clin Pharm. 2019 Jun;41(3):691-699. doi: 10.1007/s11096-019-00834-2. Epub 2019 Apr 24.

4.

Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.

Schütte LM, Cnossen MH, van Hest RM, Driessens MHE, Fijnvandraat K, Polinder S, Beckers EAM, Coppens M, Eikenboom J, Laros-van Gorkom BAP, Meijer K, Nieuwenhuizen L, Mauser-Bunschoten EP, Leebeek FWG, Mathôt RAA, Kruip MJHA.

BMJ Open. 2019 Apr 23;9(4):e022719. doi: 10.1136/bmjopen-2018-022719.

5.

Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.

van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators.

N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865.

PMID:
30893534
6.

Strategies for Individualized Dosing of Clotting Factor Concentrates and Desmopressin in Hemophilia A and B.

Preijers T, Schütte LM, Kruip MJHA, Cnossen MH, Leebeek FWG, van Hest RM, Mathôt RAA.

Ther Drug Monit. 2019 Apr;41(2):192-212. doi: 10.1097/FTD.0000000000000625. Review.

PMID:
30883513
7.

Professional functioning of young adults with congenital coagulation disorders in the Netherlands.

Limperg PF, Maurice-Stam H, Haverman L, Coppens M, Kruip MJHA, Eikenboom J, Grootenhuis MA, Peters M.

Haemophilia. 2019 May;25(3):e138-e145. doi: 10.1111/hae.13698. Epub 2019 Mar 12.

PMID:
30859671
8.

Strategies for individualized dosing of clotting factor concentrates and desmopressin in hemophilia A and B.

Preijers T, Schütte LM, Kruip MJHA, Cnossen MH, Leebeek FWG, van Hest RM, Mathôt RAA.

Ther Drug Monit. 2019 Feb 26. doi: 10.1097/FTD.0000000000000625. [Epub ahead of print]

PMID:
30817699
9.

Risk of bleeding in hospitalized patients on anticoagulant therapy: Prevalence and potential risk factors.

Dreijer AR, Diepstraten J, Brouwer R, Croles FN, Kragten E, Leebeek FWG, Kruip MJHA, van den Bemt PMLA.

Eur J Intern Med. 2019 Apr;62:17-23. doi: 10.1016/j.ejim.2019.01.008. Epub 2019 Jan 25.

PMID:
30686662
10.

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.

Orsi FA, Biedermann JS, Kruip MJHA, van der Meer FJ, Rosendaal FR, van Hylckama Vlieg A, Bos MHA, Leebeek FWG, Cannegieter SC, Lijfering WM.

J Thromb Haemost. 2019 Feb;17(2):319-328. doi: 10.1111/jth.14364. Epub 2019 Feb 3.

PMID:
30565854
11.

No effect of PCSK9 inhibitors on D-dimer and fibrinogen levels in patients with familial hypercholesterolemia.

Schol-Gelok S, Galema-Boers JAMH, van Gelder T, Kruip MJHA, Roeters van Lennep JE, Versmissen J.

Biomed Pharmacother. 2018 Dec;108:1412-1414. doi: 10.1016/j.biopha.2018.09.164. Epub 2018 Oct 6.

12.

Performance of idarucizumab as antidote of dabigatran in daily clinical practice.

van der Wall SJ, van Rein N, van den Bemt B, Kruip MJHA, Meijer K, Te Boome LCJ, Simmers TA, Alings AMW, Tieleman R, Klok FA, Huisman MV, Westerweel PE.

Europace. 2019 Mar 1;21(3):414-420. doi: 10.1093/europace/euy220.

PMID:
30339226
13.

Hemophilia B in a female with intellectual disability caused by a deletion of Xq26.3q28 encompassing the F9.

Stoof SCM, Kersseboom R, de Vries FAT, Kruip MJHA, Kievit AJA, Leebeek FWG.

Mol Genet Genomic Med. 2018 Nov;6(6):1220-1224. doi: 10.1002/mgg3.425. Epub 2018 Sep 27.

14.

Anticoagulant medication errors in hospitals and primary care: a cross-sectional study.

Dreijer AR, Diepstraten J, Bukkems VE, Mol PGM, Leebeek FWG, Kruip MJHA, van den Bemt PMLA.

Int J Qual Health Care. 2019 Jun 1;31(5):346-352. doi: 10.1093/intqhc/mzy177.

PMID:
30165484
15.

Venous thrombosis during olanzapine treatment: a complex association.

Dijkstra ME, van der Weiden CFS, Schol-Gelok S, Muller-Hansma AHG, Cohen G, van den Bemt PMLA, Kruip MJHA.

Neth J Med. 2018 Aug;76(6):263-268.

16.

Medication and venous thromboembolism: a complex interaction.

Schol-Gelok S, Kruip MJHA, Versmissen J.

Neth J Med. 2018 Aug;76(6):261-262. No abstract available.

17.

Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate.

Brekelmans MPA, Abdoellakhan RA, Scheres LJJ, Biedermann JS, Hutten BA, Meijer K, Cate HT, Huisman MV, Kruip MJHA, Middeldorp S, Coppens M.

Res Pract Thromb Haemost. 2017 Nov 13;2(1):77-84. doi: 10.1002/rth2.12055. eCollection 2018 Jan.

18.

Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.

Nieuwenburg SAV, Vuik FER, Kruip MJHA, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):866-872. doi: 10.1136/gutjnl-2018-316344. Epub 2018 Jun 5.

PMID:
29871970
19.

Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal.

Moesker MJ, Damen NL, Volmeijer EE, Dreesens D, de Loos EM, Vink R, Coppens M, Kruip MJ, Meijer K, Langelaan M, de Bruijne MC, Wagner C.

Thromb Res. 2018 Aug;168:5-13. doi: 10.1016/j.thromres.2018.05.028. Epub 2018 May 26.

PMID:
29864630
20.

Clinical effects of antiplatelet drugs and statins on D-dimer levels.

Schol-Gelok S, van der Hulle T, Biedermann JS, van Gelder T, Klok FA, van der Pol LM, Versmissen J, Huisman MV, Kruip MJHA.

Eur J Clin Invest. 2018 Jul;48(7):e12944. doi: 10.1111/eci.12944. Epub 2018 May 13.

21.

Development of a clinical prediction model for an international normalised ratio ≥ 4·5 in hospitalised patients using vitamin K antagonists.

Dreijer AR, Biedermann JS, Diepstraten J, Lindemans AD, Kruip MJHA, van den Bemt PMLA, Vergouwe Y.

Br J Haematol. 2018 Apr;181(1):102-110. doi: 10.1111/bjh.15161. Epub 2018 Mar 14.

22.

Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A Patients.

Schütte LM, van Hest RM, Stoof SCM, Leebeek FWG, Cnossen MH, Kruip MJHA, Mathôt RAA.

Thromb Haemost. 2018 Apr;118(4):621-629. doi: 10.1160/TH17-06-0390. Epub 2018 Feb 19.

PMID:
29458233
23.

Rosuvastatin use improves measures of coagulation in patients with venous thrombosis.

Biedermann JS, Kruip MJHA, van der Meer FJ, Rosendaal FR, Leebeek FWG, Cannegieter SC, Lijfering WM.

Eur Heart J. 2018 May 14;39(19):1740-1747. doi: 10.1093/eurheartj/ehy014.

PMID:
29394348
24.

Desmopressin in moderate hemophilia A patients: a treatment worth considering.

Loomans JI, Kruip MJHA, Carcao M, Jackson S, van Velzen AS, Peters M, Santagostino E, Platokouki H, Beckers E, Voorberg J, van der Bom JG, Fijnvandraat K; RISE consortium.

Haematologica. 2018 Mar;103(3):550-557. doi: 10.3324/haematol.2017.180059. Epub 2018 Jan 5.

25.

Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.

Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW.

BMJ. 2017 Oct 26;359:j4452. doi: 10.1136/bmj.j4452. Review.

26.

No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism.

van der Pol LM, van der Hulle T, Cheung YW, Mairuhu ATA, Schaar CG, Faber LM, Ten Wolde M, Hofstee HMA, Hovens MMC, Nijkeuter M, van Klink RCJ, Kruip MJHA, Middeldorp S, Huisman MV, Klok FA.

J Thromb Haemost. 2017 Dec;15(12):2317-2324. doi: 10.1111/jth.13852. Epub 2017 Oct 24.

PMID:
28941051
27.

Health-related quality of life, developmental milestones, and self-esteem in young adults with bleeding disorders.

Limperg PF, Haverman L, Maurice-Stam H, Coppens M, Valk C, Kruip MJHA, Eikenboom J, Peters M, Grootenhuis MA.

Qual Life Res. 2018 Jan;27(1):159-171. doi: 10.1007/s11136-017-1696-0. Epub 2017 Sep 12.

28.

Variation in Blood Transfusion and Coagulation Management in Traumatic Brain Injury at the Intensive Care Unit: A Survey in 66 Neurotrauma Centers Participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study.

Huijben JA, van der Jagt M, Cnossen MC, Kruip MJHA, Haitsma IK, Stocchetti N, Maas AIR, Menon DK, Ercole A, Maegele M, Stanworth SJ, Citerio G, Polinder S, Steyerberg EW, Lingsma HF.

J Neurotrauma. 2017 Nov 21. doi: 10.1089/neu.2017.5194. [Epub ahead of print]

29.

Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen.

Stoof SCM, Schütte LM, Leebeek FWG, Cnossen MH, Kruip MJHA.

Haemophilia. 2017 Nov;23(6):861-867. doi: 10.1111/hae.13295. Epub 2017 Jun 21.

PMID:
28636264
30.

Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.

van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA.

Thromb Haemost. 2017 Jul 26;117(8):1622-1629. doi: 10.1160/TH17-02-0076. Epub 2017 Jun 1.

PMID:
28569924
31.

Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study.

van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group.

Lancet. 2017 Jul 15;390(10091):289-297. doi: 10.1016/S0140-6736(17)30885-1. Epub 2017 May 23. Erratum in: Lancet. 2017 Jul 15;390(10091):230.

PMID:
28549662
32.

Sensor-based gait analysis as a simple tool to measure gait in haemophilia patients.

Stoof SCM, Hodgins D, Leebeek FWG, Cnossen MH, Horemans HLD, Praet SFE, Kruip MJHA.

Haemophilia. 2017 Jul;23(4):e355-e358. doi: 10.1111/hae.13226. Epub 2017 May 12. No abstract available.

PMID:
28497894
33.

Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.

van Rein N, Biedermann JS, van der Meer FJM, Cannegieter SC, Wiersma N, Vermaas HW, Reitsma PH, Kruip MJHA, Lijfering WM.

J Thromb Haemost. 2017 Jul;15(7):1386-1391. doi: 10.1111/jth.13715. Epub 2017 May 30.

34.

Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study.

Biedermann JS, Rademacher WMH, Hazendonk HCAM, van Diermen DE, Leebeek FWG, Rozema FR, Kruip MJHA.

Thromb Haemost. 2017 Jun 27;117(7):1432-1439. doi: 10.1160/TH17-01-0040. Epub 2017 Apr 13.

PMID:
28405671
35.

Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply.

Biedermann JS, van den Besselaar AM, van der Meer FJ, Adriaansen HJ, Leebeek FW, Kruip MJ.

Thromb Haemost. 2017 Apr 3;117(4):820-821. doi: 10.1160/TH17-02-0120. Epub 2017 Mar 16. No abstract available.

PMID:
28300868
36.

Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue-extract thromboplastins.

Biedermann JS, van den Besselaar AM, de Maat MP, Leebeek FW, Kruip MJ.

J Thromb Haemost. 2017 Mar;15(3):500-506. doi: 10.1111/jth.13611. Epub 2017 Feb 15.

37.

Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocol.

Dreijer AR, Kruip MJ, Diepstraten J, Polinder S, Brouwer R, Leebeek FW, Vulto AG, van den Bemt PM.

BMJ Open. 2016 Dec 20;6(12):e011537. doi: 10.1136/bmjopen-2016-011537.

38.

Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility.

Lijfering WM, Biedermann JS, Kruip MJ, Leebeek FW, Rosendaal FR, Cannegieter SC.

Expert Rev Hematol. 2016 Nov;9(11):1023-1030. Epub 2016 Oct 21. Review.

PMID:
27759438
39.

Statin use decreases coagulation in users of vitamin K antagonists.

van Rein N, Biedermann JS, Bonafacio SM, Kruip MJ, van der Meer FJ, Lijfering WM.

Eur J Clin Pharmacol. 2016 Dec;72(12):1441-1447. Epub 2016 Oct 5.

40.

Pharmacokinetic-guided dosing of factor VIII concentrate in a patient with haemophilia during renal transplantation.

Hazendonk HC, Kruip MJ, Mathôt RA, Cnossen MH.

BMJ Case Rep. 2016 Sep 22;2016. pii: bcr2016217069. doi: 10.1136/bcr-2016-217069.

41.

Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study: reply.

Biedermann JS, van den Besselaar AM, Leebeek FW, Kruip MJ.

J Thromb Haemost. 2016 Nov;14(11):2312-2314. doi: 10.1111/jth.13485. Epub 2016 Oct 3. No abstract available.

42.

Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation.

van den Besselaar AM, Biedermann JS, van der Meer FJ, Adriaansen HJ, Leebeek FW, Kruip MJ.

Thromb Haemost. 2016 Sep 27;116(4):679-86. doi: 10.1160/TH16-03-0184. Epub 2016 Jul 7.

PMID:
27384264
43.

Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia.

Libourel EJ, Klerk CPW, van Norden Y, de Maat MPM, Kruip MJ, Sonneveld P, Löwenberg B, Leebeek FWG.

Blood. 2016 Oct 6;128(14):1854-1861. doi: 10.1182/blood-2016-02-701094. Epub 2016 Jun 28.

44.

A diagnostic approach to mild bleeding disorders.

Boender J, Kruip MJ, Leebeek FW.

J Thromb Haemost. 2016 Aug;14(8):1507-16. doi: 10.1111/jth.13368. Epub 2016 Jun 27. Review.

45.

OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients.

Libourel EJ, Klerk C, van Norden Y, de Maat MP, Kruip MJ, Sonneveld P, Löwenberg B, Leebeek FW.

Thromb Res. 2016 Apr;140 Suppl 1:S172. doi: 10.1016/S0049-3848(16)30127-X. Epub 2016 Apr 8.

PMID:
27161682
46.

Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial.

Biedermann JS, Cannegieter SC, Roest M, van der Meer FJ, Reitsma PH, Kruip MJ, Lijfering WM.

J Thromb Haemost. 2016 Jul;14(7):1404-9. doi: 10.1111/jth.13343. Epub 2016 Jun 10.

47.

Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study.

Biedermann JS, van Rein N, van den Besselaar AM, Buhre PN, de Maat MP, van der Meer FJ, Leebeek FW, Kruip MJ.

J Thromb Haemost. 2016 Apr;14(4):695-703. doi: 10.1111/jth.13272. Epub 2016 Mar 30.

48.

How do patients and professionals differentiate between intra-articular joint bleeds and acute flare-ups of arthropathy in patients with haemophilia?

Timmer MA, Pisters MF, de Kleijn P, Veenhof C, Laros-van Gorkom BA, Kruip MJ, de Bie RA, Schutgens RE.

Haemophilia. 2016 May;22(3):368-73. doi: 10.1111/hae.12858. Epub 2015 Dec 3.

PMID:
26634961
49.

Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.

Bartels M, van der Zalm MM, van Oirschot BA, Lee FS, Giles RH, Kruip MJ, Gitz-Francois JJ, Van Solinge WW, Bierings M, van Wijk R.

Hum Mutat. 2015 Nov;36(11):1039-42. doi: 10.1002/humu.22846. Epub 2015 Aug 17.

PMID:
26224408
50.

Point-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist.

van den Besselaar AM, Biedermann JS, Kruip MJ.

Thromb Haemost. 2015 Nov 25;114(6):1260-7. doi: 10.1160/TH15-02-0128. Epub 2015 Jul 23.

PMID:
26202616

Supplemental Content

Loading ...
Support Center